Sabra Healthcare REIT Inc (NASDAQ: SBRA) started the day on Wednesday, with a price decrease of -4.25% at $16.90, before settling in for the price of $17.65 at the close. Taking a more long-term approach, SBRA posted a 52-week range of $12.83-$20.03.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Real Estate sector firm’s annual sales growth was 1.01%. Meanwhile, its Annual Earning per share during the time was -47.68%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 743.33%. This publicly-traded company’s shares outstanding now amounts to $236.59 million, simultaneously with a float of $232.73 million. The organization now has a market capitalization sitting at $4.00 billion. At the time of writing, stock’s 50-day Moving Average stood at $18.47, while the 200-day Moving Average is $16.27.
Sabra Healthcare REIT Inc (SBRA) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the REIT – Healthcare Facilities Industry. Sabra Healthcare REIT Inc’s current insider ownership accounts for 1.63%, in contrast to 97.28% institutional ownership. According to the most recent insider trade that took place on May 22 ’24, this organization’s Director bought 7,000 shares at the rate of 14.43, making the entire transaction reach 101,010 in total value, affecting insider ownership by 46,385. Preceding that transaction, on May 14 ’24, Company’s Director sold 10,000 for 14.68, making the whole transaction’s value amount to 146,830. This particular insider is now the holder of 63,923 in total.
Sabra Healthcare REIT Inc (SBRA) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.16 per share during the current fiscal year.
Sabra Healthcare REIT Inc’s EPS increase for this current 12-month fiscal period is 743.33% and is forecasted to reach 0.71 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 68.77% through the next 5 years, which can be compared against the -47.68% growth it accomplished over the previous five years trading on the market.
Sabra Healthcare REIT Inc (NASDAQ: SBRA) Trading Performance Indicators
Let’s observe the current performance indicators for Sabra Healthcare REIT Inc (SBRA). The Stock has managed to achieve an average true range (ATR) of 0.46. Alongside those numbers, its PE Ratio stands at $40.79, and its Beta score is 1.23. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.77. Similarly, its price to free cash flow for trailing twelve months is now 12.93.
In the same vein, SBRA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.41, a figure that is expected to reach 0.16 in the next quarter, and analysts are predicting that it will be 0.71 at the market close of one year from today.
Technical Analysis of Sabra Healthcare REIT Inc (SBRA)
If we take a close look at the recent performances of Sabra Healthcare REIT Inc (NASDAQ: SBRA), its last 5-days Average volume was 2.51 million that shows progress from its year to date volume of 2.05 million. During the previous 9 days, stock’s Stochastic %D was recorded 14.41% While, its Average True Range was 0.47.
Raw Stochastic average of Sabra Healthcare REIT Inc (SBRA) in the period of the previous 100 days is set at 26.35%, which indicates a major rise in contrast to 0.43% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 22.12% that was lower than 24.96% volatility it exhibited in the past 100-days period.